• Educational resources
  • Events
  • Expert Panel
  • Learning Hub
    Learning Hub
    • EoE Learning Hub
    • Type 2 Asthma Learning Hub
    • Atopic Dermatitis Learning Hub
    • Bullous Pemphigoid Learning Hub
    • COPD Learning Hub
    • Prurigo Nodularis Learning Hub
    • Rhinology Learning Hub
    • Chronic Spontaneous Urticaria Learning Hub
    • Your Catalyst Learning Hub: Advancing Respiratory Treatment Paradigms
    • Your Navigator Learning Hub: Guiding Personalized Patient Journeys
    • Your Steward Learning Hub: Upholding Excellence in Everyday Practice
No matches
  • Cookie policy
  • Privacy policy
  • About us
  • Join ADVENT

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2026 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-US-2305040 v4.0 – P Expiration Date: 10/16/2027

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: United StatesChange country/region

Educational Resources

Categories
Dermatology: 
  • Atopic dermatitis
  • Bullous pemphigoid
  • Chronic pruritus of unknown origin
  • Chronic spontaneous urticaria
  • Prurigo nodularis
Gastroenterology: 
  • Eosinophilic esophagitis
Pulmonology: 
  • Asthma
  • Chronic obstructive pulmonary disease
  • IL-33
Rhinology: 
  • Chronic rhinosinusitis with nasal polyps
Filters
Topic: 
  • Burden of disease
  • Pathophysiology
  • Guidelines and recommendations
  • Clinical management
  • Co-existing type 2 inflammatory diseases
Format: 
  • Expert Video
  • Podcast
  • Slide presentation
  • Infographic
  • Video animation
  • Interactivity
Length: 
  • Short (<5 minutes)
  • Medium (5-15 minutes)
  • Long (> 15 minutes)
Sort by: Newest
  • Newest
  • Oldest
  • A-Z
  • Z-A
Diagnostic Approaches for Bullous Pemphigoid With Variable Manifestations
Dermatology
2 min
expert video

Diagnostic Approaches for Bullous Pemphigoid With Variable Manifestations

Exploring the Potential Role of Biomarkers in Managing Bullous Pemphigoid
Dermatology
2 min
expert video

Exploring the Potential Role of Biomarkers in Managing Bullous Pemphigoid

Bullous Pemphigoid Is an Autoimmune Disease Involving Dysregulated Type 2 Immune Response
Dermatology
2 min
expert video

Bullous Pemphigoid Is an Autoimmune Disease Involving Dysregulated Type 2 Immune Response

Bullous Pemphigoid Is a Challenging Disease to Manage
Dermatology
2 min
expert video

Bullous Pemphigoid Is a Challenging Disease to Manage

Type 2 Inflammation Is a Driving Factor for Atopic Dermatitis and Related Comorbidities
Dermatology
2 min
expert video

Type 2 Inflammation Is a Driving Factor for Atopic Dermatitis and Related Comorbidities

Prurigo Nodularis Management Goals: From Itch Control to Improved Quality of Life
Dermatology
2 min
expert video

Prurigo Nodularis Management Goals: From Itch Control to Improved Quality of Life

Essential Tools for Effective Care of Patients With Chronic Spontaneous Urticaria
Dermatology
2 min
expert video

Essential Tools for Effective Care of Patients With Chronic Spontaneous Urticaria

Key Pathophysiological Mechanisms of Chronic Spontaneous Urticaria Are Driven by Type 2 Inflammation
Dermatology
2 min
expert video

Key Pathophysiological Mechanisms of Chronic Spontaneous Urticaria Are Driven by Type 2 Inflammation

Prurigo Nodularis Is a Challenging Diagnosis
Dermatology
2 min
expert video

Prurigo Nodularis Is a Challenging Diagnosis

Neuroimmune Dysfunction Is Critical in the Pathophysiology of Prurigo Nodularis
Dermatology
2 min
expert video

Neuroimmune Dysfunction Is Critical in the Pathophysiology of Prurigo Nodularis

    1234
    ...
    23